SCHEMBL25409814

SCHEMBL25409814

COc1ccc(C=O)c2c1N(S(=O)(=O)c1ccc(C)cc1)C[C@@H]2Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ ALDH1A1 P00352 4/20 0.37
▸ NLRP3 Q96P20 1/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ STAT3 P40763 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ UBE2N P61088 1/20 0.36
▸ PKM P14618 2/20 0.36
▸ LMNA P02545 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ THRB P10828 1/20 0.35
▸ GAA P10253 2/20 0.35
▸ CMA1 P23946 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ FOLH1 Q04609 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25409822 1.00 MEN1 (0.41) MEN1KMT2AALDH1A1NLRP3KDM4E
SCHEMBL26307916 0.87 ALDH1A1 (0.36) MEN1KMT2AALDH1A1KDM4ESTAT3
SCHEMBL25412424 0.86 ALDH1A1 (0.39) MEN1KMT2AALDH1A1NLRP3KDM4E
SCHEMBL25412418 0.86 ALDH1A1 (0.39) MEN1KMT2AALDH1A1NLRP3KDM4E
SCHEMBL25410726 0.83 HTR6 (0.40) MEN1KMT2AALDH1A1NLRP3KDM4E
SCHEMBL25410730 0.83 HTR6 (0.40) MEN1KMT2AALDH1A1NLRP3KDM4E
SCHEMBL25411441 0.81 ALDH1A1 (0.40) ALDH1A1NLRP3KDM4EUBE2NPKM
SCHEMBL25411450 0.81 ALDH1A1 (0.40) ALDH1A1NLRP3KDM4EUBE2NPKM
SCHEMBL25411629 0.80 HTR6 (0.43) MEN1KMT2AALDH1A1NLRP3KDM4E
SCHEMBL25411625 0.80 HTR6 (0.43) MEN1KMT2AALDH1A1NLRP3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278959-A1 Synthesis of Optically Active Indoline Derivatives Via Ruthenium(II)-Catalyzed Enantioselective C-H Functionalization MISSISSIPPI STATE UNIVERSITY 2023-09-07 — — US disclosed
US-20230278959-A1 Synthesis of Optically Active Indoline Derivatives Via Ruthenium(II)-Catalyzed Enantioselective C-H Functionalization MISSISSIPPI STATE UNIVERSITY 2023-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278959-A1 Synthesis of Optically Active Indoline Derivatives Via Ruthenium(II)-Catalyzed Enantioselective C-H Functionalization INMT, IDO2, WEE2 MEN1 4424/4885KMT2A 1855/4885ALDH1A1 3453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback